Browsing Category
Antivirals for Covid-19
11 posts
Omicron, Its Mutations, and the Antibody Response
Want a wider suite of antibodies than you can get from being dosed with a single monoclonal? Get…
Novel Antiviral Approach To Covid-19 Treatment
Novartis and Molecular Partners initiated a global clinical trial called EMPATHY, to test “ensovibep“ ForbesWilliam A. HaseltineJan 20,…
3 new pandemic strategies by 2 winners of the 2019 Nobel Prize in Economics.
1.Relying on population-wide vaccination is not working. 2.Other treatments seem more promising. 3.Rich countries must make smarter investments in…
Fight COVID-19 with lessons learned from HIV
We must reckon with the unpleasant reality that our vaccines have failed to protect against infection and transmission,…
UK life sciences trade group calls for oral Covid-19 antiviral investment
The UK government needs to further invest in Covid-19 oral antivirals to tackle the SARS-CoV-2 virus and its…
Pfizer’s New Antiviral Drug Could Transform The Pandemic, But Challenges Still Lie Ahead
ForbesWilliam A. HaseltineDecember 23, 2021 A researcher works with the COVID-19 antiviral pill, Paxlovid, at a laboratory in…
Test and treat: a missing link in the global fight against COVID-19
The newly published efficacy of a repurposed antidepressant, fluvoxamine, heralds an important shift for primary care. Fluvoxamine is joined…
The Covid Moonshot: Crowdsourcing To Develop The First Open-Source, Generic COVID-19 Antiviral Pill
A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated — and freely released — more…
Vacinas podem não ser suficientes contra ômicron, diz CEO da BioNTech
Segundo Ugur Sahin, a vacina perde eficácia com o tempo Poder36020.dez.2021Drs. Ugur Sahin and Ozlem Tureci, Co-founders, BioNTech, @…
This anti-Covid pill changes everything. So why won’t it be available for all?
Paxlovid is expected to work well against Omicron. The real problem is that production is insufficient The Guardian,…